In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Forest will market Lundbeck's antidepressant in the US

Executive Summary

Forest Laboratories has licensed US marketing rights to the antidepressant citalopram, a selective serotonin reuptake inhibitor (SSRI), from privately owned H. Lundbeck, a Danish company specializing in central nervous system drugs.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register